Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
| Main Authors: | , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2005
|
| _version_ | 1826294226984370176 |
|---|---|
| author | Mihaylova, B Armitage, J Briggs, A Gray, A Parish, S Collins, R Collaborati, H |
| author_facet | Mihaylova, B Armitage, J Briggs, A Gray, A Parish, S Collins, R Collaborati, H |
| author_sort | Mihaylova, B |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T03:42:23Z |
| format | Conference item |
| id | oxford-uuid:be55f53c-0449-44b6-a0a9-1b05be522a05 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T03:42:23Z |
| publishDate | 2005 |
| record_format | dspace |
| spelling | oxford-uuid:be55f53c-0449-44b6-a0a9-1b05be522a052022-03-27T05:38:40ZEconomic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trialConference itemhttp://purl.org/coar/resource_type/c_5794uuid:be55f53c-0449-44b6-a0a9-1b05be522a05Symplectic Elements at Oxford2005Mihaylova, BArmitage, JBriggs, AGray, AParish, SCollins, RCollaborati, H |
| spellingShingle | Mihaylova, B Armitage, J Briggs, A Gray, A Parish, S Collins, R Collaborati, H Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial |
| title | Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial |
| title_full | Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial |
| title_fullStr | Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial |
| title_full_unstemmed | Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial |
| title_short | Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial |
| title_sort | economic analysis of simvastatin in 20 536 people at different levels of vascular disease risk based on us costs randomised placebo controlled trial |
| work_keys_str_mv | AT mihaylovab economicanalysisofsimvastatinin20536peopleatdifferentlevelsofvasculardiseaseriskbasedonuscostsrandomisedplacebocontrolledtrial AT armitagej economicanalysisofsimvastatinin20536peopleatdifferentlevelsofvasculardiseaseriskbasedonuscostsrandomisedplacebocontrolledtrial AT briggsa economicanalysisofsimvastatinin20536peopleatdifferentlevelsofvasculardiseaseriskbasedonuscostsrandomisedplacebocontrolledtrial AT graya economicanalysisofsimvastatinin20536peopleatdifferentlevelsofvasculardiseaseriskbasedonuscostsrandomisedplacebocontrolledtrial AT parishs economicanalysisofsimvastatinin20536peopleatdifferentlevelsofvasculardiseaseriskbasedonuscostsrandomisedplacebocontrolledtrial AT collinsr economicanalysisofsimvastatinin20536peopleatdifferentlevelsofvasculardiseaseriskbasedonuscostsrandomisedplacebocontrolledtrial AT collaboratih economicanalysisofsimvastatinin20536peopleatdifferentlevelsofvasculardiseaseriskbasedonuscostsrandomisedplacebocontrolledtrial |